A detailed history of Amalgamated Bank transactions in Chroma Dex Corp. stock. As of the latest transaction made, Amalgamated Bank holds 1,694 shares of CDXC stock, worth $8,978. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,694
Previous 1,694 -0.0%
Holding current value
$8,978
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$2.44 - $4.32 $4,133 - $7,318
1,694 New
1,694 $5,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $12,133 - $20,603
-7,631 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$2.02 - $3.92 $15,414 - $29,913
7,631 New
7,631 $19,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $362M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.